American College Of Cardiology Recommends Empagliflozin As Preferred Sglt2 Inhibitor For Adults With Type 2 | Latest News RSS feed

American College Of Cardiology Recommends Empagliflozin As Preferred Sglt2 Inhibitor For Adults With Type 2 - Latest News


American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 ...

INGELHEIM, Germany & INDIANAPOLIS, Ind. — A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empagliflozin as the preferred SGLT2 inhibitor for its p... read more

ACC recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes

A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends Jardiance (empagliflozin) as the preferred SGLT2 inhibitor for its proven benefit in reducing the ... read more

Cardiology association recommends Lilly's Jardiance for lowering CV risk in type 2 diabetics

and alliance partner Boehringer Ingelheim announce that the American College of Cardiology (ACC) recommends Jardiance (empagliflozin) as the preferred SGLT2 inhibitor for reducing cardiovascular (CV) ... read more

Looking for another news?


AHA names top heart disease and stroke research advances of 2017

The AHA and American College of Cardiology released new guidelines for adults last November ... than 300,000 patients with Type 2 diabetes in the U.S., the U.K., Denmark, Norway and Sweden. The result... read more


An update on type 2 diabetes management in primary care

2 The Eighth Joint National Committee (JNC-8) consolidated recommendations for BP management ... to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology ... read more

Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes: A Systematic Review and Meta-analysis

Dr. Matthews: Harris Manchester College, Mansfield Road ... and 3 reviewers summarized strength of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. read more

Heart Disease Is a Major Killer If You Have Diabetes

Watson, professor of medicine and cardiology, co-director of the UCLA Program in ... found in a survey that 52 percent of adults with Type 2 diabetes don’t know that they are at a higher risk for hear... read more

Type 2 Diabetes

(3).FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes. [Online] Available at: https:/www.fda.gov/newsevents/newsroom/pressannouncements/ucm531517.htm [Accessed on: 1... read more

Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed?

The patient is a 48-year-old African-American man with type 2 diabetes diagnosed at age 41 on laboratory testing when his A1C was found to be 10.8%. At diagnosis, he was 73 inches tall and weighed 337 ... read more

Top heart disease and stroke research advances of 2017

The AHA and American College of Cardiology released new guidelines for adults last November ... than 300,000 patients with Type 2 diabetes in the U.S., the U.K., Denmark, Norway and Sweden. The result... read more

Bolstering your armamentarium with SGLT2 inhibitors

Abstract: Sodium-glucose cotransporter-2 inhibitors have a unique mechanism of action in the kidneys Journal Logo Secondary Logo Account Saved Searches Recent Searches Register Activate Subscription L... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us